GFVCX
Price
$15.37
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
58.59M
VFFSX
Price
$310.68
Change
+$2.25 (+0.73%)
Updated
Aug 6 closing price
Net Assets
1.49T
Interact to see
Advertisement

GFVCX vs VFFSX

Header iconGFVCX vs VFFSX Comparison
Open Charts GFVCX vs VFFSXBanner chart's image
Goldman Sachs Focused Value C
Price$15.37
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets58.59M
Vanguard 500 Index Institutional Select
Price$310.68
Change+$2.25 (+0.73%)
VolumeN/A
Net Assets1.49T
GFVCX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFVCX vs. VFFSX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFVCX is a Hold and VFFSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.49T vs. GFVCX (58.6M). VFFSX pays higher dividends than GFVCX: VFFSX (1.20) vs GFVCX (0.42). GFVCX was incepted earlier than VFFSX: GFVCX (10 years) vs VFFSX (9 years). GFVCX (2.43) is less costly to investors than VFFSX (0.01). GFVCX is a more actively managed with annual turnover of: 85.00 vs. VFFSX (2.00). GFVCX has a lower initial minimum investment than VFFSX: GFVCX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 20.30 vs. GFVCX (3.55). VFFSX return over 5 years is better than : 88.16 vs. GFVCX (43.25).
GFVCXVFFSXGFVCX / VFFSX
Total Expense Ratio1.760.0117,600%
Annual Report Gross Expense Ratio2.430.0124,300%
Fund Existence10 years9 years-
Gain YTD1.5867.21122%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets58.6M1.49T0%
Annual Yield % from dividends0.421.2035%
Returns for 1 year3.5520.3017%
Returns for 3 years19.8052.1338%
Returns for 5 years43.2588.1649%
Returns for 10 years59.09N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.470.06
+1.76%
Arbutus Biopharma Corp
CUK26.780.01
+0.04%
Carnival PLC
SOL1.86N/A
N/A
Emeren Group Ltd
HOOK0.90-0.02
-1.86%
HOOKIPA Pharma Inc.
KYMR41.35-1.62
-3.77%
Kymera Therapeutics